Skip to content
DeepViews

Canopy Growth Corporation Common Shares (CGC) — Analysis Summary

Canopy Growth Corporation Common Shares (CGC) has a market cap of $320.45M with year-over-year revenue growth of +6.9%. Net margin stands at -92.4%. The stock trades at a P/E ratio of -1.7.

Key Takeaways

  • Revenue changed +6.9% year-over-year
  • Net margin of -92.4%
  • P/E ratio of -1.7

Compared to other companies in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, CGC posted revenue growth of +6.9% and trades at a P/E of -1.7.

[XNAS]

Canopy Growth Corporation Common Shares (CGC)

$0.76

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$320.45M
Enterprise Value
$226.21M
P/E Ratio
-1.7
Div Yield
126.73%
EV/EBITDA
-2.2
Company Profile
About
About Canopy Growth Corporation Common Shares

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

Sector

MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

Employees

1,128

Headquarters

SMITH FALLS, A6

Exchange

XNAS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
29
No Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$500.61M
Total Debt$167.46M
Debt-to-Equity0.33
Cash & Equivalents$261.70M

Cash Flow

Operating Cash Flow$-46.22M
Free Cash Flow$-50.08M
FCF Margin-24.29%
P/FCF Ratio-6.40
Source: Polygon.io · SEC EDGAR
Dividends
Dividends

Annual Dividend/Share

$0.96

Dividend Yield

126.73%

Quarterly
Last Ex-Date: 2007-08-01

Dividend History

2007-08-01
CD$0.2400
2007-04-26
CD$0.2400
2007-01-29
CD$0.2400
2006-10-27
CD$0.2400
Source: Polygon.io
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.